Andrew Gillman

Andrew Gillman

Wilson Sonsini Goodrich & Rosati

Contact
View Bio
RSS

Latest Posts › Life Sciences

Share:

2024 Technology and Life Sciences IPO Report

Wilson Sonsini's 2024 Technology and Life Sciences IPO Report provides in-depth analysis on 33 initial public offerings (IPOs) completed by U.S.-based technology and life sciences companies in 2024 with deal values exceeding...more

2/28/2025  /  Capital Markets , Financial Services Industry , Initial Public Offering (IPO) , Investment , Life Sciences , Publicly-Traded Companies , Securities , Securities and Exchange Commission (SEC) , Securities Regulation , Technology Sector

2023 Technology and Life Sciences IPO Report

Market volatility, high interest rates, and ongoing geopolitical conflict continue to influence low levels of IPO activity in the U.S. capital markets. The trend is observed across all sectors, resulting in IPO levels similar...more

3/29/2024  /  Board of Directors , Corporate Governance , Emerging Growth Companies , Emerging Technology Companies , Initial Public Offering (IPO) , Life Sciences , Non-GAAP Financial Measures , Technology Sector
2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide